Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–20. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Chumanevich AA, Poudyal D, Cui X, Davis T, Wood PA, Smith CD, Hofseth LJ. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis. 2010;31:1787–1793. doi:10.1093/carcin/bgq158.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Card T, Logan R, Leufkens H. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005;54:1573–1578. doi:10.1136/gut.2005.070896.
   PubMed Web of Science ®Google Scholar
• B Vendramini-Costa D, E Carvalho J. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des. 2012;18:3831–3852. doi:10.2174/138161212802083707.
   PubMed Web of Science ®Google Scholar
• Wang D, DuBois RN. The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med. 2013;64:131–144. doi:10.1146/annurev-med-112211-154330.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633. doi:10.1053/j.gastro.2004.03.024.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields J. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut. 2003;52:720–728. doi:10.1136/gut.52.5.720.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293:G729–G38. doi:10.1152/ajpgi.00132.2007.
   PubMed Web of Science ®Google Scholar
• Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 2010;31:246–251. doi:10.1093/carcin/bgp197.
   PubMed Web of Science ®Google Scholar
• Genaro SC, de Souza Reis LSL, Reis SK, Socca EAR, Fávaro WJ. Probiotic supplementation attenuates the aggressiveness of chemically induced colorectal tumor in rats. Life Sci. 2019;237:116895. doi:10.1016/j.lfs.2019.116895.
   PubMed Web of Science ®Google Scholar
• Rong J, Liu S, Hu C, Liu C. Single probiotic supplement suppresses colitis‐associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis. J Gastroenterol Hepatol. 2019;34:1182–1192. doi:10.1111/jgh.14516.
   PubMed Web of Science ®Google Scholar
• Oh NS, Lee JY, Oh S, Joung JY, Kim SG, Shin YK, Lee K-W, Kim SH, Kim Y. Improved functionality of fermented milk is mediated by the synbiotic interaction between Cudrania tricuspidata leaf extract and Lactobacillus gasseri strains. Appl Microbiol Biotechnol. 2016;100:5919–5932. doi:10.1007/s00253-016-7414-y.
   PubMed Web of Science ®Google Scholar
• Oh NS, Lee JY, Joung JY, Kim KS, Shin YK, Lee K-W, Kim SH, Oh S, Kim Y. Microbiological characterization and functionality of set-type yogurt fermented with potential prebiotic substrates Cudrania tricuspidata and Morus alba L. Leaf Extracts J Dairy Sci. 2016;99:6014–6025. doi:10.3168/jds.2015-10814.
   PubMed Web of Science ®Google Scholar
• Oh NS, Lee JY, Kim Y. The growth kinetics and metabolic and antioxidant activities of the functional synbiotic combination of Lactobacillus gasseri 505 and Cudrania tricuspidata leaf extract. Appl Microbiol Biotechnol. 2016;100:10095–10106. doi:10.1007/s00253-016-7863-3.
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim SG, Shin YK, Oh NS. Immunomodulatory effects of fermented milk based on synbiotic interaction between Cudrania tricuspidata leaf extract and Lactobacillus gasseri 505. J Milk Sci Biotechnol. 2018;36:39–48. doi:10.22424/jmsb.2018.36.1.39.
   Google Scholar
• Sies H, De Groot H. Role of reactive oxygen species in cell toxicity. Toxicol Lett. 1992;64:547–551. doi:10.1016/0378-4274(92)90230-H.
   PubMed Web of Science ®Google Scholar
• Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471–475. doi:10.1038/35068566.
   PubMed Web of Science ®Google Scholar
• Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta Biomembr. 2009;1788:872–891. doi:10.1016/j.bbamem.2008.11.005.
   PubMed Web of Science ®Google Scholar
• Jacobs MD, Harrison SC. Structure of an IκBα/NF-κB complex. Cell. 1998;95:749–758. doi:10.1016/S0092-8674(00)81698-0.
   PubMed Web of Science ®Google Scholar
• Stepanović S, Dakić I, Martel A, Vaneechoutte M, Morrison D, Shittu A, Ježek P, Decostere A, Devriese LA, Haesebrouck F. A comparative evaluation of phenotypic and molecular methods in the identification of members of the Staphylococcus sciuri group. Syst Appl Microbiol. 2005;28:353–357. doi:10.1016/j.syapm.2005.02.001.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1087–G96. doi:10.1152/ajpgi.00124.2010.
   PubMed Web of Science ®Google Scholar
• Pan F, Zhang L, Li M, Hu Y, Zeng B, Yuan H, Zhao L, Zhang C. Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie-restricted mice. Microbiome. 2018;6:54. doi:10.1186/s40168-018-0440-5.
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. In: Macia L, editor. Advances in immunology. Vol. 121. Cambridge (MA): Elsevier; 2014. p. 91–119.
   Google Scholar
• LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017;16:79. doi:10.1186/s12934-017-0691-z.
   PubMed Web of Science ®Google Scholar
• Sun Y, O’Riordan MX. Regulation of bacterial pathogenesis by intestinal short-chain fatty acids. In: O’Riordan MX, editor. Advances in applied microbiology. Vol. 85. Cambridge (MA): Elsevier; 2013. p. 93–118.
   Google Scholar
• Jurk D, Wilson C, Passos JF, Oakley F, Correia-Melo C, Greaves L, Saretzki G, Fox C, Lawless C, Anderson R. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun. 2014;5:4172. doi:10.1038/ncomms5172.
   Web of Science ®Google Scholar
• Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, Umetsu DT, Rudensky AY. Extrathymically generated regulatory T cells control mucosal TH 2 inflammation. Nature. 2012;482:395–399. doi:10.1038/nature10772.
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382–392. doi:10.1016/j.chom.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, Saini R, De Vito D, Inchingolo F. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: a randomized double-blinded placebo-controlled pilot study. Endocr Metab Immune Disord Drug Targets. 2019;19:373–381. doi:10.2174/1871530319666181221150352.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Fordjour L, Ahmad A, Cai C, Kumar D, Valencia G, Aranda JV, Beharry KD. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res. 2010;67:526–531. doi:10.1203/PDR.0b013e3181d4ff2b.
   PubMed Web of Science ®Google Scholar
• Jones RM, Desai C, Darby TM, Luo L, Wolfarth AA, Scharer CD, Ardita CS, Reedy AR, Keebaugh ES, Neish AS. Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep. 2015;12:1217–1225. doi:10.1016/j.celrep.2015.07.042.
   PubMed Web of Science ®Google Scholar
• Matthews JD, Owens JA, Naudin CR, Saeedi BJ, Alam A, Reedy AR, Hinrichs BH, Sumagin R, Neish AS, Jones RM. Neutrophil-derived reactive oxygen orchestrates epithelial cell signaling events during intestinal repair. Am J Pathol. 2019;189:2221–2232. doi:10.1016/j.ajpath.2019.07.017.
   PubMed Web of Science ®Google Scholar
• Parang B, Barrett CW, Williams CS. AOM/DSS model of colitis-associated cancer. In: Williams CS editor. Gastrointestinal physiology and diseases. New York (NY): Springer; 2016. p. 297–307.
   Google Scholar
• De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9. doi:10.4103/1477-3163.78279.
   PubMedGoogle Scholar
• Santiago C, Pagán B, Isidro AA, Appleyard CB. Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer. Cancer Res. 2007;67:10766–10773. doi:10.1158/0008-5472.CAN-07-1418.
   PubMed Web of Science ®Google Scholar
• Chung I-C, OuYang C-N, Yuan S-N, Lin H-C, Huang K-Y, Wu P-S, Liu C-Y, Tsai K-J, Loi L-K, Chen Y-J. Pretreatment with a heat-killed probiotic modulates the NLRP3 inflammasome and attenuates colitis-associated colorectal cancer in mice. Nutrients. 2019;11:516. doi:10.3390/nu11030516.
   Web of Science ®Google Scholar
• Jeong J-K, Chang H-K, Park K-Y. Doenjang prepared with mixed starter cultures attenuates azoxymethane and dextran sulfate sodium-induced colitis-associated colon carcinogenesis in mice. J Carcinog. 2014;13:9. doi:10.4103/1477-3163.137699.
   Google Scholar
• Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. In: Grivennikov SI editor. Seminars in Immunopathology. New York (NY): Springer; 2013. p. 229–244.
   Google Scholar
• Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112:1557–1569. doi:10.1182/blood-2008-05-078154.
   PubMed Web of Science ®Google Scholar
• Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med. 1997;337:1720–1725. doi:10.1056/NEJM199712113372403.
   PubMed Web of Science ®Google Scholar
• Kanda Y, Osaki M, Okada F. Chemopreventive strategies for inflammation-related carcinogenesis: current status and future direction. Int J Mol Sci. 2017;18:867. doi:10.3390/ijms18040867.
   Web of Science ®Google Scholar
• Saito Y, Hinoi T, Adachi T, Miguchi M, Niitsu H, Kochi M, Sada H, Sotomaru Y, Sakamoto N, Sentani K. Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model. PLoS One. 2019;14:e0216393. doi:10.1371/journal.pone.0216393.
   PubMed Web of Science ®Google Scholar
• Shinde T, Perera AP, Vemuri R, Gondalia SV, Karpe AV, Beale DJ, Shastri S, Southam B, Eri R, Stanley R. Synbiotic supplementation containing whole plant sugar cane fibre and probiotic spores potentiates protective synergistic effects in mouse model of IBD. Nutrients. 2019;11:818. doi:10.3390/nu11040818.
   Web of Science ®Google Scholar
• Yan S, Yang B, Zhao J, Zhao J, Stanton C, Ross RP, Zhang H, Chen W. A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct. 2019;10:1595–1608. doi:10.1039/C9FO00014C.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, West NE, Pillai R, Taggart DP, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39:1088–1094. doi:10.1161/01.HYP.0000018041.48432.B5.
   PubMed Web of Science ®Google Scholar
• Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034–2037. doi:10.1126/science.276.5321.2034.
   PubMed Web of Science ®Google Scholar
• Wink DA, Cook JA, Kim SY, Vodovotz Y, Pacelli R, Krishna MC, Russo A, Mitchell JB, Jourd’heuil D, Miles AM. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem. 1997;272:11147–11151. doi:10.1074/jbc.272.17.11147.
   PubMed Web of Science ®Google Scholar
• Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113:427–437. doi:10.1111/j.1365-2567.2004.01984.x.
   PubMed Web of Science ®Google Scholar
• Kolios G, Brown Z, Robson RL, Robertson DA, Westwick J. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT‐29. Brit J Pharmacol. 1995;116:2866–2872. doi:10.1111/j.1476-5381.1995.tb15938.x.
   PubMed Web of Science ®Google Scholar
• Kolios G, Rooney N, Murphy C, Robertson D, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 1998;43:56–63. doi:10.1136/gut.43.1.56.
   PubMed Web of Science ®Google Scholar
• Khan KNM, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int. 2002;61:1210–1219. doi:10.1046/j.1523-1755.2002.00263.x.
   PubMed Web of Science ®Google Scholar
• Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol. 1997;75:1088–1095. doi:10.1139/y97-130.
   PubMed Web of Science ®Google Scholar
• Yang G, Lee K, Lee M, Ham I, Choi H-Y. Inhibition of lipopolysaccharide-induced nitric oxide and prostaglandin E2 production by chloroform fraction of Cudrania tricuspidata in RAW 264.7 macrophages. BMC Complement Altern Med. 2012;12:250. doi:10.1186/1472-6882-12-250.
   PubMed Web of Science ®Google Scholar
• Fábrega M-J, Rodríguez-Nogales A, Garrido-Mesa J, Algieri F, Badía J, Giménez R, Gálvez J, Baldomà L. Intestinal anti-inflammatory effects of outer membrane vesicles from Escherichia coli Nissle 1917 in DSS-experimental colitis in mice. Front Microbiol. 2017;8:1274. doi:10.3389/fmicb.2017.01274.
   PubMed Web of Science ®Google Scholar
• Madara J, Pappenheimer J. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J Membr Biol. 1987;100:149–164. doi:10.1007/BF02209147.
   PubMed Web of Science ®Google Scholar
• Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase–dependent barrier dysfunction mediates T cell activation–induced diarrhea in vivo. J Clin Invest. 2005;115:2702–2715. doi:10.1172/JCI24970.
   PubMed Web of Science ®Google Scholar
• Kawashima R, Kawakami F, Maekawa T, Yamamoto H, Koizumi W, Ichikawa T. Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration. Cancer Chemother Pharmacol. 2015;76:269–277. doi:10.1007/s00280-015-2790-z.
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Miquel S, Noordine M-L, Bouet S, Chevalier-Curt MJ, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. doi:10.1186/1741-7007-11-61.
   PubMed Web of Science ®Google Scholar
• Fishman JE, Levy G, Alli V, Sheth S, Lu Q, Deitch EA. Oxidative modification of the intestinal mucus layer is a critical but unrecognized component of trauma hemorrhagic shock-induced gut barrier failure. Am J Physiol Gastrointest Liver Physiol. 2013;304:G57–G63. doi:10.1152/ajpgi.00170.2012.
   PubMed Web of Science ®Google Scholar
• Silva SD, Robbe-Masselot C, Ait-Belgnaoui A, Mancuso A, Mercade-Loubière M, Salvador-Cartier C, Gillet M, Ferrier L, Loubière P, Dague E. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am J Physiol Gastrointest Liver Physiol. 2014;307:G420–G9. doi:10.1152/ajpgi.00290.2013.
   PubMed Web of Science ®Google Scholar
• Hasnain SZ, Tauro S, Das I, Tong H, Chen ACH, Jeffery PL, McDonald V, Florin TH, McGuckin MA. IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology. 2013;144:357–68. e9. doi:10.1053/j.gastro.2012.10.043.
   PubMed Web of Science ®Google Scholar
• Burger-van Paassen N, Van der Sluis M, Bouma J, Korteland-van Male AM, Lu P, Van Seuningen I, Boehm G, van Goudoever JB, Renes IB. Colitis development during the suckling-weaning transition in mucin Muc2-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2011;301:G667–G78. doi:10.1152/ajpgi.00199.2010.
   PubMed Web of Science ®Google Scholar
• Kouznetsova I, Peitz U, Vieth M, Meyer F, Vestergaard EM, Malfertheiner P, Roessner A, Lippert H, Hoffmann W. A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa. Cell Tissue Res. 2004;316:155–165. doi:10.1007/s00441-004-0854-1.
   PubMed Web of Science ®Google Scholar
• Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777–1788. doi:10.1083/jcb.123.6.1777.
   PubMed Web of Science ®Google Scholar
• Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986;103:755–766. doi:10.1083/jcb.103.3.755.
   PubMed Web of Science ®Google Scholar
• Beatch M, Jesaitis LA, Gallin WJ, Goodenough DA, Stevenson BR. The tight junction protein ZO-2 contains three PDZ (PSD-95/Discs-Large/ZO-1) domains and an alternatively spliced region. J Biol Chem. 1996;271:25723–25726. doi:10.1074/jbc.271.42.25723.
   PubMed Web of Science ®Google Scholar
• Citi S, Sabanay H, Jakes R, Geiger B, Kendrick-Jones J. Cingulin, a new peripheral component of tight junctions. Nature. 1988;333:272–276. doi:10.1038/333272a0.
   PubMed Web of Science ®Google Scholar
• D’atri F, Citi S. Cingulin interacts with F‐actin in vitro. FEBS Lett. 2001;507:21–24. doi:10.1016/S0014-5793(01)02936-2.
   PubMed Web of Science ®Google Scholar
• Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. 2005;166:409–419. doi:10.1016/S0002-9440(10)62264-X.
   PubMed Web of Science ®Google Scholar
• Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008;180:5653–5661. doi:10.4049/jimmunol.180.8.5653.
   PubMed Web of Science ®Google Scholar
• Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest. 2006;86:191–201. doi:10.1038/labinvest.3700373.
   PubMed Web of Science ®Google Scholar
• Stillwell W. Chapter 24 - cell death, apoptosis. In: Stillwell W, editor. An introduction to biological membranes. 2nd ed. Cambridge (MA): Elsevier; 2016. p. 539–546.
   Google Scholar
• Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485–495. doi:10.1093/carcin/21.3.485.
   PubMed Web of Science ®Google Scholar
• Toshiyuki M, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293–299. doi:10.1016/0092-8674(95)90412-3.
   PubMed Web of Science ®Google Scholar
• Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem. 1999;274:2225–2233. doi:10.1074/jbc.274.4.2225.
   PubMed Web of Science ®Google Scholar
• Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334. doi:10.1038/348334a0.
   PubMed Web of Science ®Google Scholar
• Park H-A, Licznerski P, Mnatsakanyan N, Niu Y, Sacchetti S, Wu J, Polster BM, Alavian KN, Jonas EA. Inhibition of Bcl-xL prevents pro-death actions of ΔN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity. Cell Death Differ. 2017;24:1963–1974. doi:10.1038/cdd.2017.123.
   PubMed Web of Science ®Google Scholar
• Satyanarayana A, Hilton MB, Kaldis P. p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell. 2008;19:65–77. doi:10.1091/mbc.e07-06-0525.
   PubMed Web of Science ®Google Scholar
• Brantley DM, Chen C-L, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr LD, Yull FE. Nuclear factor-κB (NF-κB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell. 2001;12:1445–1455. doi:10.1091/mbc.12.5.1445.
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Ghosh S. The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034. doi:10.1101/cshperspect.a000034.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242:540–546. doi:10.1126/science.3140380.
   PubMed Web of Science ®Google Scholar
• Li Vivian SW, Ng Ser S, Boersema Paul J, Low Teck Y, Karthaus Wouter R, Gerlach Jan P, Mohammed S, Heck Albert JR, Maurice Madelon M, Mahmoudi T, et al. Wnt Signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell. 2012;149:1245–1256. doi:10.1016/j.cell.2012.05.002.
   PubMed Web of Science ®Google Scholar
• Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, Dorobek M, Hausmanowa-Petrusewicz I, Ramaekers FCS, Broers JLV, Blankesteijn WM, et al. The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. Embo J. 2006;25:3275–3285. doi:10.1038/sj.emboj.7601230.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer. 2000;82:1689–1693. doi:10.1054/bjoc.1999.1112.
   PubMed Web of Science ®Google Scholar
• Voronkov A, Krauss S. Wnt/beta-catenin signaling and small molecule inhibitors. Curr Pharm Des. 2013;19:634–664. doi:10.2174/138161213804581837.
   PubMed Web of Science ®Google Scholar
• Peters BA, Dominianni C, Shapiro JA, Church TR, Wu J, Miller G, Yuen E, Freiman H, Lustbader I, Salik J. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4:69. doi:10.1186/s40168-016-0218-6.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Jeffery IB, Conde S, Power SE, O’connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O’Sullivan O. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178–184. doi:10.1038/nature11319.
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–185. doi:10.1038/nature10809.
   PubMed Web of Science ®Google Scholar
• Huang G, Khan I, Li X, Chen L, Leong W, Ho LT, Hsiao WW. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc Min/+ mice. Sci Rep. 2017;7:12552. doi:10.1038/s41598-017-12644-5.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Hall JC, Wang L, Mo X, Yu Z, Popovich PG. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016;213:2603–2620. doi:10.1084/jem.20151345.
   PubMed Web of Science ®Google Scholar
• Hong Y-S, Ahn Y-T, Park J-C, Lee J-H, Lee H, Huh C-S, Kim D-H, Ryu DH, Hwang G-S. 1 H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model. Arch Pharm Res. 2010;33:1091–1101. doi:10.1007/s12272-010-0716-1.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Lane D. 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M editors. Nucleic acid techniques in bacterial systematics. Hoboken (NJ): John Wiley and Sons; 1991. p. 115–175.
   Google Scholar
• Kim O-S, Cho Y-J, Lee K, Yoon S-H, Kim M, Na H, Park S-C, Jeon YS, Lee J-H, Yi H. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Sys Evol Microbiol. 2012;62:716–721. doi:10.1099/ijs.0.038075-0.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335. doi:10.1038/nmeth.f.303.
   PubMed Web of Science ®Google Scholar
• Hoving LR, Heijink M, van Harmelen V, van Dijk KW, Giera M. GC-MS analysis of short-chain fatty acids in feces, cecum content, and blood samples. In: Giera M editor. Clinical metabolomics. methods in molecular biology. New York (NY): Springer; 2018. p. 247–256.
   Google Scholar